SCINAI IMMUNOTHERAPEUTICS LTD. Key Management Personnel Compensation
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Key Management Personnel Compensation of ILS 14.49 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-28.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensation · last filed 2022-03-28
ILS
| Period end | Key Management Personnel Compensation 12 month | Key Management Personnel Compensation 12 month as first filed |
|---|---|---|
| 2021-12-31 | 14.49M ILS 20-F · filed 2022-03-28 | |
| 2020-12-31 | 6.90M ILS 20-F · filed 2022-03-28 | |
| 2019-12-31 | 7.05M ILS 20-F · filed 2022-03-28 | 9.05M ILS 20-F · filed 2020-06-12 |
| 2018-12-31 | 2.72M ILS 20-F · filed 2021-05-13 | |
| 2017-12-31 | 2.67M ILS 20-F · filed 2020-06-12 | |
| 2016-12-31 | 2.97M ILS 20-F · filed 2019-04-30 | |
| 2015-12-31 | 2.57M ILS 20-F · filed 2018-04-30 |
USD
| Period end | Key Management Personnel Compensation 12 month |
|---|---|
| 2021-12-31 | $4.66M 20-F · filed 2022-03-28 |
| 2020-12-31 | $2.15M 20-F · filed 2021-05-13 |
| 2017-12-31 | $771.00K 20-F · filed 2018-04-30 |